Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-06-06 @ 5:38 PM
Study NCT ID:
NCT01689558
Status:
UNKNOWN
Last Update Posted:
2013-03-12
First Post:
2012-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer
Sponsor:
Jin Feng
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20111220
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None